ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch
By filer · By stock

$WVE:NASDAQ · Wave Life Sciences Ltd

Sector: health

Conviction from: NASDAQCitrini

52-week range: 4.2021.73

Wave Life Sciences is a clinical-stage biotechnology company developing RNA-targeting and RNA-editing genetic medicines for neurological and other diseases.

2 tracked filer(s) hold this · 0 opened, 1 added, 0 trimmed in 30-JUN-2026

Aggregate 13FScore 86 — mean of 2 scored holder(s) · buyers (new/add) avg 76. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Steve Cohen / Point7276Added +3965%1,487,789$8,644,0540.0%
Stanley Druckenmiller / Duquesne95Holds (flat)173,000$1,0050.0%

Beyond 13F — activists, insiders, politicians & research

Activist 13D filings daily digest →

FiledFormActivist% of classConviction
2026-04-17SCHEDULE 13D/ARA CAPITAL MANAGEMENT, L.P.17.1%Highfiling
2026-03-30SCHEDULE 13D/ARA CAPITAL MANAGEMENT, L.P.17.5%Highfiling

Insider open-market buys daily digest →

FiledInsiderRoleSharesValue
2026-03-30RA CAPITAL MANAGEMENT, L.P.director+10%-owner8,772,496$54,624,378Form 4

Citrini Research coverage report library →

ReportDateStance
#80 — Market Memo: January Musings2025-01-09LONG

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-09-24.